Seizert Capital Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-70,719
Closed -$1.09M 207
2020
Q3
$1.09M Sell
70,719
-7,481
-10% -$115K 0.07% 113
2020
Q2
$1.19M Sell
78,200
-12,986
-14% -$193K 0.08% 103
2020
Q1
$1.16M Sell
91,186
-76,653
-46% -$1.37M 0.09% 96
2019
Q4
$4.04M Buy
167,839
+84,021
+100% +$1.92M 0.2% 62
2019
Q3
$1.77M Hold
83,818
0.09% 96
2019
Q2
$1.85M Sell
83,818
-3,679
-4% -$85.4K 0.09% 102
2019
Q1
$2.07M Buy
+87,497
New +$2.04M 0.09% 95

Other funds holding TBI

Seizert Capital Partners's TBI Position: Q4 2020 in Review

Seizert Capital Partners sold out of Trueblue (TBI) in Q4 2020, closing a stake of 70,719 shares — an estimated $1.09M sold.

Seizert Capital Partners first reported a position in TBI in Q1 2019 and held it in 7 quarters. The position peaked at $4.04M in Q4 2019. 155 funds tracked by Wall St. Rank hold TBI as of Q4 2020.

  • Seizert Capital Partners reported no remaining Trueblue position as of Q4 2020 after selling out during the quarter.
  • Seizert Capital Partners sold 70,719 Trueblue shares in Q4 2020, an estimated $1.09M.
  • Seizert Capital Partners first reported a position in Trueblue in Q1 2019 and held it in 7 quarters.
  • Seizert Capital Partners's Trueblue position peaked at $4.04M in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Trueblue as of Q4 2020.

Based on Seizert Capital Partners's 13F filing for Q4 2020, filed 8 Feb 2021.